Categories: News | No Comments
Just three years ago, a global shortage of the antimalarial natural product artemisinin alarmed medics fighting the killer disease, and spurred scientists who were developing alternative sources of the drug.
Yet a glut of the compound has now saturated the market to such a degree that prices have slumped, threatening to put some Chinese drug manufacturers out of business. And Africa – where around a million children die of malaria every year – still isn’t getting enough of the drug.
Read the full story here.